Inflammation in First-episode Psychosis: The Contribution of Inflammatory Biomarkers to the Emergence of Negative Symptoms, a Systematic Review and Meta-analysis

Overview

Journal Acta Psychiatr Scand

Specialty Psychiatry

Date 2022 Feb 24

PMID 35202480

Authors

Connor Dunleavy

Richard J Elsworthy

Rachel Upthegrove

Stephen J Wood

Sarah Aldred

Affiliations

Soon will be listed here.

Abstract

Objective: To provide a comprehensive analysis of cytokine perturbations in antipsychotic-naïve first-episode psychosis (FEP) populations and assess the relationship between inflammatory biomarkers and negative symptom severity.

Methods: A systematic review and meta-analysis following PRISMA guidelines were conducted. A total of 1042 records were identified via systematic search of EMBASE, MEDLINE and APA PsycInfo databases. Sixteen studies met the inclusion criteria and were eligible for inclusion in the review. Ten of these studies had sufficient data for inclusion in a random effects, pooled-effect meta-analysis.

Results: A significant and large effect size was reported for IFN-γ, IL-6 and IL-12, and a moderate effect size reported for IL-17 (p = <0.05) in people with antipsychotic naive first episode psychosis, compared to healthy controls, suggesting a significant elevation in proinflammatory cytokine concentration. Non-significant effect sizes were reported for TNF-α, IL-1β, IL-2, IL-4, IL-8 and IL-10 (p = >0.05). Regarding proinflammatory cytokines and relationships to negative symptomology, moderate positive relationships were reported for negative symptoms and IL-1β, IL-2, IL-6 and TNF-α, across four studies. For anti-inflammatory cytokines, one strong and one weak-to-moderate negative relationship was described for IL-10 and negative symptoms. Contrastingly, a strong positive relationship was reported for IL-4 and negative symptoms.

Conclusion: There is evidence of significantly elevated proinflammatory cytokines in antipsychotic-naïve FEP populations, alongside promising findings from cohort data suggesting an interaction between inflammation and primary negative symptomology. Future studies should seek to come to a consensus on a panel of cytokines that relate most specifically to negative symptoms, and consider longitudinal studies to investigate how cytokine fluctuations may relate to exacerbation of symptoms.

Citing Articles

Theoretical Potential of Hericium Erinaceus Supplementation as an Add-On to Antipsychotics in Chronic and Treatment-Resistant Schizophrenia.

Baker J, Newman S Psychopharmacol Bull. 2025; 55(2):41-59.

PMID: 39935672 PMC: 11809503.

Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels.

Corsi-Zuelli F, Donohoe G, Griffiths S, Del-Ben C, Watson A, Burke T Biol Psychiatry Glob Open Sci. 2025; 5(2):100429.

PMID: 39911538 PMC: 11795630. DOI: 10.1016/j.bpsgos.2024.100429.

Impact of neuroinflammation on brain glutamate and dopamine signalling in schizophrenia: an update.

Nayak U, Manikkath J, Arora D, Mudgal J Metab Brain Dis. 2025; 40(2):119.

PMID: 39907868 PMC: 11799129. DOI: 10.1007/s11011-025-01548-3.

Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism.

Qiu Z, Guo J, Chen B, Fang J Biomolecules. 2025; 15(1).

PMID: 39858450 PMC: 11762389. DOI: 10.3390/biom15010056.

Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations.

Bortoletto R, Comacchio C, Garzitto M, Piscitelli F, Balestrieri M, Colizzi M Brain Behav Immun Health. 2025; 43():100927.

PMID: 39839988 PMC: 11745966. DOI: 10.1016/j.bbih.2024.100927.

References

Fraguas D, Diaz-Caneja C, Ayora M, Hernandez-Alvarez F, Rodriguez-Quiroga A, Recio S . Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis. Schizophr Bull. 2018; 45(4):742-751. PMC: 6581144. DOI: 10.1093/schbul/sby125. View

Joaquim H, Costa A, Gattaz W, Talib L . Kynurenine is correlated with IL-1β in plasma of schizophrenia patients. J Neural Transm (Vienna). 2018; 125(5):869-873. DOI: 10.1007/s00702-018-1838-8. View

Tsuang M . Schizophrenia: genes and environment. Biol Psychiatry. 2000; 47(3):210-20. DOI: 10.1016/s0006-3223(99)00289-9. View

Robertson B, Prestia D, Twamley E, Patterson T, Bowie C, Harvey P . Social competence versus negative symptoms as predictors of real world social functioning in schizophrenia. Schizophr Res. 2014; 160(1-3):136-41. PMC: 4258126. DOI: 10.1016/j.schres.2014.10.037. View

Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E . Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms. Psychoneuroendocrinology. 2014; 41:23-32. DOI: 10.1016/j.psyneuen.2013.12.005. View

Upthegrove R, Manzanares-Teson N, Barnes N . Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res. 2014; 155(1-3):101-8. DOI: 10.1016/j.schres.2014.03.005. View

Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N . Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response. Schizophr Res. 2013; 147(1):103-109. DOI: 10.1016/j.schres.2013.03.027. View

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

Goldsmith D, Haroon E, Miller A, Strauss G, Buckley P, Miller B . TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophr Res. 2018; 199:281-284. PMC: 6111000. DOI: 10.1016/j.schres.2018.02.048. View

10.

Malla A, Takhar J, Norman R, Manchanda R, Cortese L, Haricharan R . Negative symptoms in first episode non-affective psychosis. Acta Psychiatr Scand. 2002; 105(6):431-9. DOI: 10.1034/j.1600-0447.2002.02139.x. View

11.

Pillinger T, Osimo E, Brugger S, Mondelli V, McCutcheon R, Howes O . A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis. Schizophr Bull. 2018; 45(5):1120-1133. PMC: 6737479. DOI: 10.1093/schbul/sby160. View

12.

Dai N, Jie H, Duan Y, Xiong P, Xu X, Chen P . Different serum protein factor levels in first-episode drug-naive patients with schizophrenia characterized by positive and negative symptoms. Psychiatry Clin Neurosci. 2020; 74(9):472-479. DOI: 10.1111/pcn.13078. View

13.

Weinberger D . Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987; 44(7):660-9. DOI: 10.1001/archpsyc.1987.01800190080012. View

14.

Fillman S, Sinclair D, Fung S, Webster M, Weickert C . Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry. 2014; 4:e365. PMC: 3944638. DOI: 10.1038/tp.2014.8. View

15.

Ripke S, ODushlaine C, Chambert K, Moran J, Kahler A, Akterin S . Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013; 45(10):1150-9. PMC: 3827979. DOI: 10.1038/ng.2742. View

16.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

17.

Wang A, Miller B . Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression. Schizophr Bull. 2017; 44(1):75-83. PMC: 5768046. DOI: 10.1093/schbul/sbx035. View

18.

Eack S, Newhill C . Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull. 2007; 33(5):1225-37. PMC: 2632363. DOI: 10.1093/schbul/sbl071. View

19.

Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X . Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology. 2020; 114:104595. DOI: 10.1016/j.psyneuen.2020.104595. View

20.

Zhang X, Cao L, Song C, Wu G, Chen D, Qi L . Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics. Psychopharmacology (Berl). 2008; 201(3):383-9. DOI: 10.1007/s00213-008-1295-4. View